Trial
NCT04173273
A Study Evaluating the Efficacy and Safety of Oral Etrasimod in the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Pfizer
Collaborators
Arena is a wholly owned subsidiary of Pfizer
Condition
Crohn's Disease
Intervention
Etrasimod
Why stopped
The study was prematurely discontinued due to a lack of efficacy in sub-study 1
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-07-01